Italy Crocin Market Size & Outlook, 2023-2030
Italy crocin market, 2018-2030 (US$M)
Related Markets
Italy crocin market highlights
- The Italy crocin market generated a revenue of USD 182.4 million in 2023 and is expected to reach USD 264.7 million by 2030.
- The Italy market is expected to grow at a CAGR of 5.5% from 2024 to 2030.
- In terms of segment, purity>98% was the largest revenue generating purity in 2023.
- Purity>98% is the most lucrative purity segment registering the fastest growth during the forecast period.
Crocin market data book summary
| Market revenue in 2023 | USD 182.4 million |
| Market revenue in 2030 | USD 264.7 million |
| Growth rate | 5.5% (CAGR from 2023 to 2030) |
| Largest segment | Purity>98% |
| Fastest growing segment | Purity>98% |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Purity>98%, Purity<98% |
| Key market players worldwide | Merck KGaA, GSK PLC, Cipla Ltd DR, Novartis AG ADR, Sanofi SA, Aurobindo Pharma, Teva Pharmaceutical Industries Ltd, Mallinckrodt PLC Ordinary Shares - New, Cayman Chemical, Tokyo Chemical Industry, APExBIO Technology, Wilshire Technologies, Biosynth |
Other key industry trends
- In terms of revenue, Italy accounted for 3.8% of the global crocin market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany crocin market is projected to lead the regional market in terms of revenue in 2030.
- Italy is the fastest growing regional market in Europe and is projected to reach USD 264.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Crocin Market Scope
Crocin Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Italy crocin market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to crocin market will help companies and investors design strategic landscapes.
Purity>98% was the largest segment with a revenue share of 95.39% in 2023. Horizon Databook has segmented the Italy crocin market based on purity>98%, purity<98% covering the revenue growth of each sub-segment from 2018 to 2030.
The only drugs recommended for fever treatment in Italy are paracetamol and ibuprofen. However, therapeutic approaches may differ depending on the setting. Paracetamol and ibuprofen are the most commonly prescribed analgesics in Italy for acute mild-moderate pain in children; however, their use is frequently inappropriate, as fever is over-treated while pain is under-treated.
Government regulatory bodies highly recommend paracetamol to treat fever and pain. For instance, the Government Scientific Committee of Italian Ministry of Health recommended acetaminophen (paracetamol) for addressing fever and pain during the early onset of the COVID-19 pandemic.
Moreover, increasing production of paracetamol and its combination drugs is expected to boost the overall market in the country. For instance, in 2021, the Italian company Angelini Pharma manufactured around 45.5 million packages of Tachipirina, which contains paracetamol.
Reasons to subscribe to Italy crocin market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Italy crocin market databook
-
Our clientele includes a mix of crocin market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Italy crocin market , including forecasts for subscribers. This country databook contains high-level insights into Italy crocin market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Italy crocin market size, by purity, 2018-2030 (US$M)
Italy Crocin Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
